Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy. Am J Nephrol. 2014; 40(1):64-74.
View in:
PubMed
subject areas
Aged
Blood Glucose
Blood Pressure
Body Weight
Canagliflozin
Clinical Trials, Phase III as Topic
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Female
Glomerular Filtration Rate
Glucosides
Glycated Hemoglobin A
Humans
Hypertension
Hypoglycemic Agents
Male
Middle Aged
Randomized Controlled Trials as Topic
Renal Insufficiency, Chronic
Severity of Illness Index
Thiophenes
Treatment Outcome
authors with profiles
George Bakris